The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Official Title: A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Study ID: NCT01541553
Brief Summary: The purpose of this trial is to compare the rate of complete clearance of actinic keratosis (AK) using sequential cryotherapy and field treatment with PEP005 Gel compared to cryotherapy alone.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Center for Dermatology Clinical Research, Freemont, California, United States
Dermatology Specialists, Inc., Oceanside, California, United States
Skin Surgery Medical Group, Inc., San Diego, California, United States
University Clinical Trials, Inc., San Diego, California, United States
Colorado Medical Research Center, Inc., Denver, Colorado, United States
About Skin Dermatology and DermSurgery, PC, Englewood, Colorado, United States
The Center for Clincial and Cosmetic Research, Aventura, Florida, United States
Study Protocol, Inc., Boynton Beach, Florida, United States
North Florida Dermatology Associates, PA, Jacksonville, Florida, United States
University of South Florida, Carol and Frank Morsani Center for Advanced Healthcare, Tampa, Florida, United States
MedaPhase, Newnan, Georgia, United States
Gwinnett Clinical Research Center, Inc., Snellville, Georgia, United States
Altman Dermatology Associates, Arlington Heights, Illinois, United States
Laser & Skin Surgery Center of Indiana, Carmel, Indiana, United States
The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
Great Lakes Research Center, Bay City, Michigan, United States
Henry Ford Medical Centre - New Center One, Department of Dermatology, Detroit, Michigan, United States
Grekin Skin Institute, Warren, Michigan, United States
Minnesota Clinical Study Center, Fridley, Minnesota, United States
Academic Dermatology Associates, Albuquerque, New Mexico, United States
Mount Sinai School of Medicine, New York, New York, United States
Skin Search of Rochester, Inc., Rochester, New York, United States
Long Island Skin Cancer and Dermatologic Surgery, Smithtown, New York, United States
Oregon Medical Research Center, PC, Portland, Oregon, United States
Oregon Health & Science University, Dept. of Dermatology, Portland, Oregon, United States
Philadelphia Institute of Dermatology, Fort Washington, Pennsylvania, United States
Dermatology Research Associates, Inc., Nashville, Tennessee, United States
Arlington Research Center, Inc., Arlington, Texas, United States
Suzanne Bruce and Associates, P.A., Houston, Texas, United States
Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, United States
Center for Clinical Studies, Webster, Texas, United States
Dermatology Research Center, Inc., Salt Lake City, Utah, United States
The Education & Research Foundation, Inc., Lynchburg, Virginia, United States
Virginia Clinical Research, Inc., Norfolk, Virginia, United States
Premier Clinical Research, Spokane, Washington, United States
Name: Brian Berman, MD, Ph.D
Affiliation:
Role: PRINCIPAL_INVESTIGATOR